Report Detail

Request for Sample of this report

Pharma & Healthcare COVID-19 Impact on Global Diagnostic Nuclear Medicines Market Insights, Forecast to 2026

  • RnM4018105
    • |
  • 09 June, 2020
    • |
  • Global
    • |
  • 116 Pages
    • |
  • QYResearch
    • |
  • Pharma & Healthcare

Diagnostic Nuclear Medicines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Diagnostic Nuclear Medicines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Diagnostic Nuclear Medicines market is segmented into
Tc-99m
F-18
Other

Segment by Application, the Diagnostic Nuclear Medicines market is segmented into
Oncology
Cardiology
Other

Regional and Country-level Analysis
The Diagnostic Nuclear Medicines market is analysed and market size information is provided by regions (countries).
The key regions covered in the Diagnostic Nuclear Medicines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Diagnostic Nuclear Medicines Market Share Analysis
Diagnostic Nuclear Medicines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Diagnostic Nuclear Medicines business, the date to enter into the Diagnostic Nuclear Medicines market, Diagnostic Nuclear Medicines product introduction, recent developments, etc.
The major vendors covered:
Bracco Imaging
Bayer
Curium Pharmaceuticals
Nordion
Triad Isotopes
Lantheus
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Novartis
SIEMENS
Dongcheng
Navidea


1 Study Coverage

  • 1.1 Diagnostic Nuclear Medicines Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Diagnostic Nuclear Medicines Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Diagnostic Nuclear Medicines Market Size Growth Rate by Type
    • 1.4.2 Tc-99m
    • 1.4.3 F-18
    • 1.4.4 Other
  • 1.5 Market by Application
    • 1.5.1 Global Diagnostic Nuclear Medicines Market Size Growth Rate by Application
    • 1.5.2 Oncology
    • 1.5.3 Cardiology
    • 1.5.4 Other
  • 1.6 Coronavirus Disease 2019 (Covid-19): Diagnostic Nuclear Medicines Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Diagnostic Nuclear Medicines Industry
      • 1.6.1.1 Diagnostic Nuclear Medicines Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Diagnostic Nuclear Medicines Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Diagnostic Nuclear Medicines Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global Diagnostic Nuclear Medicines Market Size Estimates and Forecasts
    • 2.1.1 Global Diagnostic Nuclear Medicines Revenue 2015-2026
    • 2.1.2 Global Diagnostic Nuclear Medicines Sales 2015-2026
  • 2.2 Diagnostic Nuclear Medicines Market Size by Region: 2020 Versus 2026
    • 2.2.1 Global Diagnostic Nuclear Medicines Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Diagnostic Nuclear Medicines Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Diagnostic Nuclear Medicines Competitor Landscape by Players

  • 3.1 Diagnostic Nuclear Medicines Sales by Manufacturers
    • 3.1.1 Diagnostic Nuclear Medicines Sales by Manufacturers (2015-2020)
    • 3.1.2 Diagnostic Nuclear Medicines Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Diagnostic Nuclear Medicines Revenue by Manufacturers
    • 3.2.1 Diagnostic Nuclear Medicines Revenue by Manufacturers (2015-2020)
    • 3.2.2 Diagnostic Nuclear Medicines Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Diagnostic Nuclear Medicines Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Diagnostic Nuclear Medicines Revenue in 2019
    • 3.2.5 Global Diagnostic Nuclear Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Diagnostic Nuclear Medicines Price by Manufacturers
  • 3.4 Diagnostic Nuclear Medicines Manufacturing Base Distribution, Product Types
    • 3.4.1 Diagnostic Nuclear Medicines Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Diagnostic Nuclear Medicines Product Type
    • 3.4.3 Date of International Manufacturers Enter into Diagnostic Nuclear Medicines Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Diagnostic Nuclear Medicines Market Size by Type (2015-2020)
    • 4.1.1 Global Diagnostic Nuclear Medicines Sales by Type (2015-2020)
    • 4.1.2 Global Diagnostic Nuclear Medicines Revenue by Type (2015-2020)
    • 4.1.3 Diagnostic Nuclear Medicines Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Diagnostic Nuclear Medicines Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Diagnostic Nuclear Medicines Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Diagnostic Nuclear Medicines Revenue Forecast by Type (2021-2026)
    • 4.2.3 Diagnostic Nuclear Medicines Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Diagnostic Nuclear Medicines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)

  • 5.1 Global Diagnostic Nuclear Medicines Market Size by Application (2015-2020)
    • 5.1.1 Global Diagnostic Nuclear Medicines Sales by Application (2015-2020)
    • 5.1.2 Global Diagnostic Nuclear Medicines Revenue by Application (2015-2020)
    • 5.1.3 Diagnostic Nuclear Medicines Price by Application (2015-2020)
  • 5.2 Diagnostic Nuclear Medicines Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Diagnostic Nuclear Medicines Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Diagnostic Nuclear Medicines Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Diagnostic Nuclear Medicines Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Diagnostic Nuclear Medicines by Country
    • 6.1.1 North America Diagnostic Nuclear Medicines Sales by Country
    • 6.1.2 North America Diagnostic Nuclear Medicines Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Diagnostic Nuclear Medicines Market Facts & Figures by Type
  • 6.3 North America Diagnostic Nuclear Medicines Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Diagnostic Nuclear Medicines by Country
    • 7.1.1 Europe Diagnostic Nuclear Medicines Sales by Country
    • 7.1.2 Europe Diagnostic Nuclear Medicines Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Diagnostic Nuclear Medicines Market Facts & Figures by Type
  • 7.3 Europe Diagnostic Nuclear Medicines Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Diagnostic Nuclear Medicines by Region
    • 8.1.1 Asia Pacific Diagnostic Nuclear Medicines Sales by Region
    • 8.1.2 Asia Pacific Diagnostic Nuclear Medicines Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Diagnostic Nuclear Medicines Market Facts & Figures by Type
  • 8.3 Asia Pacific Diagnostic Nuclear Medicines Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Diagnostic Nuclear Medicines by Country
    • 9.1.1 Latin America Diagnostic Nuclear Medicines Sales by Country
    • 9.1.2 Latin America Diagnostic Nuclear Medicines Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Diagnostic Nuclear Medicines Market Facts & Figures by Type
  • 9.3 Central & South America Diagnostic Nuclear Medicines Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Diagnostic Nuclear Medicines by Country
    • 10.1.1 Middle East and Africa Diagnostic Nuclear Medicines Sales by Country
    • 10.1.2 Middle East and Africa Diagnostic Nuclear Medicines Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Diagnostic Nuclear Medicines Market Facts & Figures by Type
  • 10.3 Middle East and Africa Diagnostic Nuclear Medicines Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Bracco Imaging
    • 11.1.1 Bracco Imaging Corporation Information
    • 11.1.2 Bracco Imaging Description, Business Overview and Total Revenue
    • 11.1.3 Bracco Imaging Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Bracco Imaging Diagnostic Nuclear Medicines Products Offered
    • 11.1.5 Bracco Imaging Recent Development
  • 11.2 Bayer
    • 11.2.1 Bayer Corporation Information
    • 11.2.2 Bayer Description, Business Overview and Total Revenue
    • 11.2.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Bayer Diagnostic Nuclear Medicines Products Offered
    • 11.2.5 Bayer Recent Development
  • 11.3 Curium Pharmaceuticals
    • 11.3.1 Curium Pharmaceuticals Corporation Information
    • 11.3.2 Curium Pharmaceuticals Description, Business Overview and Total Revenue
    • 11.3.3 Curium Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Curium Pharmaceuticals Diagnostic Nuclear Medicines Products Offered
    • 11.3.5 Curium Pharmaceuticals Recent Development
  • 11.4 Nordion
    • 11.4.1 Nordion Corporation Information
    • 11.4.2 Nordion Description, Business Overview and Total Revenue
    • 11.4.3 Nordion Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Nordion Diagnostic Nuclear Medicines Products Offered
    • 11.4.5 Nordion Recent Development
  • 11.5 Triad Isotopes
    • 11.5.1 Triad Isotopes Corporation Information
    • 11.5.2 Triad Isotopes Description, Business Overview and Total Revenue
    • 11.5.3 Triad Isotopes Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Triad Isotopes Diagnostic Nuclear Medicines Products Offered
    • 11.5.5 Triad Isotopes Recent Development
  • 11.6 Lantheus
    • 11.6.1 Lantheus Corporation Information
    • 11.6.2 Lantheus Description, Business Overview and Total Revenue
    • 11.6.3 Lantheus Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Lantheus Diagnostic Nuclear Medicines Products Offered
    • 11.6.5 Lantheus Recent Development
  • 11.7 GE Healthcare
    • 11.7.1 GE Healthcare Corporation Information
    • 11.7.2 GE Healthcare Description, Business Overview and Total Revenue
    • 11.7.3 GE Healthcare Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 GE Healthcare Diagnostic Nuclear Medicines Products Offered
    • 11.7.5 GE Healthcare Recent Development
  • 11.8 China Isotope & Radiation
    • 11.8.1 China Isotope & Radiation Corporation Information
    • 11.8.2 China Isotope & Radiation Description, Business Overview and Total Revenue
    • 11.8.3 China Isotope & Radiation Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 China Isotope & Radiation Diagnostic Nuclear Medicines Products Offered
    • 11.8.5 China Isotope & Radiation Recent Development
  • 11.9 Jubilant Pharma
    • 11.9.1 Jubilant Pharma Corporation Information
    • 11.9.2 Jubilant Pharma Description, Business Overview and Total Revenue
    • 11.9.3 Jubilant Pharma Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Jubilant Pharma Diagnostic Nuclear Medicines Products Offered
    • 11.9.5 Jubilant Pharma Recent Development
  • 11.10 Eli Lilly
    • 11.10.1 Eli Lilly Corporation Information
    • 11.10.2 Eli Lilly Description, Business Overview and Total Revenue
    • 11.10.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Eli Lilly Diagnostic Nuclear Medicines Products Offered
    • 11.10.5 Eli Lilly Recent Development
  • 11.1 Bracco Imaging
    • 11.1.1 Bracco Imaging Corporation Information
    • 11.1.2 Bracco Imaging Description, Business Overview and Total Revenue
    • 11.1.3 Bracco Imaging Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Bracco Imaging Diagnostic Nuclear Medicines Products Offered
    • 11.1.5 Bracco Imaging Recent Development
  • 11.12 SIEMENS
    • 11.12.1 SIEMENS Corporation Information
    • 11.12.2 SIEMENS Description, Business Overview and Total Revenue
    • 11.12.3 SIEMENS Sales, Revenue and Gross Margin (2015-2020)
    • 11.12.4 SIEMENS Products Offered
    • 11.12.5 SIEMENS Recent Development
  • 11.13 Dongcheng
    • 11.13.1 Dongcheng Corporation Information
    • 11.13.2 Dongcheng Description, Business Overview and Total Revenue
    • 11.13.3 Dongcheng Sales, Revenue and Gross Margin (2015-2020)
    • 11.13.4 Dongcheng Products Offered
    • 11.13.5 Dongcheng Recent Development
  • 11.14 Navidea
    • 11.14.1 Navidea Corporation Information
    • 11.14.2 Navidea Description, Business Overview and Total Revenue
    • 11.14.3 Navidea Sales, Revenue and Gross Margin (2015-2020)
    • 11.14.4 Navidea Products Offered
    • 11.14.5 Navidea Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Diagnostic Nuclear Medicines Market Estimates and Projections by Region
    • 12.1.1 Global Diagnostic Nuclear Medicines Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Diagnostic Nuclear Medicines Revenue Forecast by Regions 2021-2026
  • 12.2 North America Diagnostic Nuclear Medicines Market Size Forecast (2021-2026)
    • 12.2.1 North America: Diagnostic Nuclear Medicines Sales Forecast (2021-2026)
    • 12.2.2 North America: Diagnostic Nuclear Medicines Revenue Forecast (2021-2026)
    • 12.2.3 North America: Diagnostic Nuclear Medicines Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Diagnostic Nuclear Medicines Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Diagnostic Nuclear Medicines Sales Forecast (2021-2026)
    • 12.3.2 Europe: Diagnostic Nuclear Medicines Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Diagnostic Nuclear Medicines Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Diagnostic Nuclear Medicines Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Diagnostic Nuclear Medicines Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Diagnostic Nuclear Medicines Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Diagnostic Nuclear Medicines Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Diagnostic Nuclear Medicines Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Diagnostic Nuclear Medicines Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Diagnostic Nuclear Medicines Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Diagnostic Nuclear Medicines Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Diagnostic Nuclear Medicines Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Diagnostic Nuclear Medicines Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Diagnostic Nuclear Medicines Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Diagnostic Nuclear Medicines Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Diagnostic Nuclear Medicines Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Diagnostic Nuclear Medicines Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source

    Summary:
    Get latest Market Research Reports on COVID-19 Impact on Global Diagnostic Nuclear Medicines. Industry analysis & Market Report on COVID-19 Impact on Global Diagnostic Nuclear Medicines is a syndicated market report, published as COVID-19 Impact on Global Diagnostic Nuclear Medicines Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Diagnostic Nuclear Medicines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,900.00
    		$5,850.00
    		$7,800.00
    		3,108.30
    		4,662.45
    		6,216.60
    		3,623.10
    		5,434.65
    		7,246.20
    		596,427.00
    		894,640.50
    		1,192,854.00
    		325,338.00
    		488,007.00
    		650,676.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo